GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » E10

Alkem Laboratories (NSE:ALKEM) E10 : ₹113.21 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alkem Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was ₹49.760. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹113.21 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-25), Alkem Laboratories's current stock price is ₹5451.65. Alkem Laboratories's E10 for the quarter that ended in Dec. 2023 was ₹113.21. Alkem Laboratories's Shiller PE Ratio of today is 48.16.

During the past 13 years, the highest Shiller PE Ratio of Alkem Laboratories was 48.03. The lowest was 32.07. And the median was 41.74.


Alkem Laboratories E10 Historical Data

The historical data trend for Alkem Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkem Laboratories E10 Chart

Alkem Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Alkem Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 106.28 109.85 113.21

Competitive Comparison of Alkem Laboratories's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's Shiller PE Ratio falls into.



Alkem Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alkem Laboratories's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=49.76/152.9243*152.9243
=49.760

Current CPI (Dec. 2023) = 152.9243.

Alkem Laboratories Quarterly Data

per share eps CPI Adj_EPS
201203 0.000 76.889 0.000
201303 0.000 85.687 0.000
201403 21.930 91.425 36.682
201412 13.500 96.780 21.332
201503 10.999 97.163 17.311
201506 16.820 99.841 25.763
201509 22.320 101.753 33.545
201512 15.630 102.901 23.228
201603 7.250 102.518 10.815
201606 19.970 105.961 28.821
201609 23.650 105.961 34.132
201612 19.520 105.196 28.376
201703 11.460 105.196 16.659
201706 5.990 107.109 8.552
201709 26.820 109.021 37.620
201712 14.360 109.404 20.072
201803 5.610 109.786 7.814
201806 11.390 111.317 15.647
201809 21.280 115.142 28.263
201812 16.940 115.142 22.499
201903 14.000 118.202 18.113
201906 15.510 120.880 19.622
201909 31.020 123.175 38.512
201912 31.950 126.235 38.705
202003 15.780 124.705 19.351
202006 35.300 127.000 42.506
202009 39.480 130.118 46.400
202012 37.720 130.889 44.070
202103 20.080 131.771 23.304
202106 39.150 134.084 44.651
202109 45.520 135.847 51.242
202112 43.960 138.161 48.657
202203 8.990 138.822 9.903
202206 10.680 142.347 11.474
202209 27.670 144.661 29.251
202212 38.030 145.763 39.898
202303 5.930 146.865 6.175
202306 23.980 150.280 24.402
202309 51.900 151.492 52.391
202312 49.760 152.924 49.760

Add all the adjusted EPS together and divide 10 will get our e10.


Alkem Laboratories  (NSE:ALKEM) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Alkem Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5451.65/113.21
=48.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Alkem Laboratories was 48.03. The lowest was 32.07. And the median was 41.74.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alkem Laboratories E10 Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines